UK Markets closed

Elanco Animal Health Incorporated (ELAN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
31.01-0.50 (-1.59%)
At close: 4:00PM EDT

31.01 0.00 (0.00%)
After hours: 4:30PM EDT

Full screen
Trade prices are not sourced from all markets
Previous close31.51
Open31.34
Bid30.95 x 900
Ask30.96 x 900
Day's range30.57 - 31.95
52-week range15.17 - 34.09
Volume2,037,768
Avg. volume4,364,064
Market cap14.632B
Beta (5Y monthly)1.04
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • 4 Great Stocks You Can Buy With $300
    Motley Fool

    4 Great Stocks You Can Buy With $300

    This has been one of the most volatile years on record for the stock market, but it remains the greatest wealth creator over the long run. The interesting thing about investing is that every sizable decline in the stock market represents a buying opportunity. Best of all, you don't need to start with a mountain of cash to build wealth in the stock market.

  • Sachem Head takes $1.2 billion position in Elanco, stock price surges
    Reuters

    Sachem Head takes $1.2 billion position in Elanco, stock price surges

    Hedge fund Sachem Head Capital Management said on Wednesday that it owns a $1.2 billion stake in Elanco Animal Health Inc and plans to push for changes at the company that makes medicines and vaccinations for pets and livestock. The New York-based hedge fund, run by Scott Ferguson, said in a regulatory filing the Greenfield, Indiana headquartered company's stock is "undervalued" and an "attractive investment." Ferguson raised cash for the position through a so-called special purpose vehicle over the last months and his hedge fund now owns a 9.1% stake through stock and options.

  • Reuters

    Elanco to cut over 900 positions in first reorganization since Bayer unit deal

    The unit's acquisition, which was completed last month, created the world's second-largest company in the sector. Elanco said it started repayment of the loan that funded the Bayer Animal Health takeover. The job cuts primarily affect positions in sales and marketing, and also research and development, manufacturing and quality, the company said.